Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Surgery
100%
Non Small Cell Lung Cancer
83%
Lobectomy
62%
Thorax Surgery
58%
Heart Function
52%
Recurrent Disease
49%
Lung Cancer
43%
Hiatus Hernia
41%
Small Intestine Obstruction
41%
Hernioplasty
41%
Chest Tube
39%
Tube Removal
34%
Ischemia
33%
Adenosine Triphosphate
31%
Adenocarcinoma
30%
Tumor Marker
30%
Empyema
30%
Fluorodeoxyglucose
27%
Gastrectomy
27%
Positron Emission Tomography
27%
Esophageal Cancer
27%
Thorax Radiography
27%
Video-Assisted Thoracoscopic Surgery
26%
Standardized Uptake Value
26%
Health Care Cost
24%
Chest Radiograph
23%
Injury
23%
Heart Muscle Ischemia
23%
Hazard Ratio
22%
Overall Survival
21%
Neoplasm
21%
Obstruction
19%
Proportional Hazards Model
18%
Pneumothorax
18%
Minimally Invasive Procedure
18%
Malignant Neoplasm
18%
Lymph Node
17%
Esophagectomy
16%
Heart Ventricle Function
16%
Cancer
16%
Cancer Cell
15%
Heart Muscle Revascularization
15%
Quality Improvement
15%
Diseases
15%
Stereotactic Body Radiation Therapy
15%
Quality of Life
15%
Propensity Score Matching
14%
Abdominal Wall Hernia
13%
Stromal Cell
13%
Carcinoma
13%
Keyphrases
Non-small Cell Lung Cancer (NSCLC)
80%
Lung Cancer
57%
Lobectomy
50%
Intestinal Obstruction
41%
Hazard Ratio
38%
Chest Tube Drainage
37%
Ischemia
35%
Esophageal Cancer
34%
Thoracic Surgery
34%
Improved Survival
31%
Empyema
30%
Standardized Uptake Value
28%
Fascin
27%
Preoperative Chemotherapy
27%
Gastrectomy
27%
Tumor Marker
27%
Ethyl Pyruvate
27%
Cancer Metastasis
27%
Reperfusion
27%
Video-assisted Thoracoscopic Surgery
27%
Propensity Score Matching
27%
Myocardial Function
24%
Lytic Therapy
23%
Minimally Invasive Surgery
23%
Readmission
22%
Single Institution
21%
Chest X-ray
20%
Surgery Patients
20%
Adenocarcinoma
20%
Non-associated
20%
5-year Survival
19%
Myocardial Ischemia
19%
R0 Resection
19%
Sublobar Resection
19%
Tissue Plasminogen Activator (t-PA)
18%
Patient Characteristics
18%
Survival Benefit
18%
Cox Proportional Hazards Model
18%
Minimally Invasive Approach
18%
Cardiac Function
17%
Metastasis Suppressor
17%
Carcinoma in Situ
17%
Gross Total Resection
17%
Spontaneous Pneumothorax
17%
Induction Therapy
17%
Odds Ratio
17%
Survival Analysis
16%
Esophagectomy
16%
Ventricular Dysfunction
16%
Surgical Intervention
16%